Our research centers on deciphering the mechanisms controlling antitumor immunity and employ this knowledge to devise the next-generation cancer immunotherapies
Can serotonin and SSRIs help T cells kill cancer?
Our @CellCellPress article by Dr. Bo Li, doctoral candidate James Elsten-Brown and their team reports "Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis!"
https://t.co/iWXyD8T7hK
A new protocol from PICI Investigator Lili Yang, PhD, (@UCLA) published in @CellPressNews, lets scientists track cancer-fighting cells in real time as they move through the body — offering insight for safer, more effective therapies that combine precision targeting with immune power.
Read the full paper from @LiliYangLab: https://t.co/WVvJj5YUlM
#CancerResearch #CellTherapy #Immunotherapy #NKTcells #PICI
Could your antidepressant be moonlighting as a cancer fighter? 🧠🛡️ New UCLA research suggests SSRIs might help supercharge the immune system against cancer. Mood-lifting and life-saving? #TCSC#CancerResearch#Immunotherapy#SSRI#UCLA#MentalHealth https://t.co/rlRqkd1ATA
@Fake_JimBrown@SeanS1755 We're excited for him to continue producing exciting, quality research like other high-achieving PhD candidates in our lab such as Kuangyi
SSRI Antidepressants May Also Be Anticancer
“It turns out SSRIs don’t just make our brains happier; they also make our T cells happier—even while they’re fighting tumors,” say researchers led by Lili Yang, PhD, at @UCLA.
#antidepressants#cancer
https://t.co/0SQKvNINzl
It's #TylerTuesday!
Last week PhD Candidate Tyler Halladay shared his research on Engineering iPSC-derived gdT cells for solid tumor therapy with his UCLA Pharmacology community. Thanks for representing our lab, Tyler!
Could SSRI Antidepressants Help Fight Cancer?
These drugs have been widely and safely used to treat depression for decades, repurposing them for cancer would be easier than developing an entirely new therapy.
@UCLA@LiliYangLab#cancer#DrugRepurposing
https://t.co/1jTVFQneLD
Congrats to Dr. Bo Li and James Elsten-Brown on earning second place in
@UCLATDG's #LABEST conference poster competition for their work on SERT regulation of serotonin-dependent antitumor immunity, based on their research in https://t.co/PbwOecZ5kv Way to go, boys!